Case study - Whitepaper: Philips Capital

Access to advanced health technology through innovative financing solutions

At a glance

Company:

Whitepaper

Trade sector:

Healthcare

Market:

International

Challenge:

How to finance healthcare technologies from Philips

Results:

Access to advanced health technology through innovative financing solutions

How we made it happen:

Healthcare facilities turn to Philips Capital and Atradius Dutch State Business for export state-of-the-art healthcare technology from the Netherlands

Trade finance provides the fluidity and security needed to allow for the movement of goods and services.

Bob Baren Bob Barre
Atradius DSB

Export Credit Agency Financing Structure

Atradius Dutch State Business (Atradius DSB), the Dutch government’s Export Credit Agency (ECA), plays an active role in healthcare financing transactions. Atradius DSB’s purpose is to facilitate the financing of exports and increase the competitive advantage of national enterprises in foreign markets. 

The ECA Financing Structure allows crossborder healthcare providers access to hard currency financing to purchase Philips medical equipment. Philips Capital works through a global network of financiers and ECAs, such as Atradius DSB. Export credit support, available from other ECAs, can vary in accordance with national rules and regulations. 

Another significant advantage of an ECA solution is the timeframe for a transaction’s payback structure, which can be up to seven years. This is a considerable advantage, as banks tend to be reluctant to finance transactions with such a long risk horizon.

Philips is improving people’s health and well-being

Philips enhances people’s health and well-being through meaningful innovation and aims to improve 2.5 billion lives per year by 2030. Regarding healthcare as a connected whole - helping people live healthier by giving clinicians the advanced technology necessary to make precise diagnosis, deliver personalized treatment, and aid in the patient’s recovery at home. All efforts are supported by a seamless flow of insightful clinical and patient data.

With a proud heritage of ground-breaking innovation that stretches back almost 130 years. Meaningful innovation – focused on care providers’ needs – remains at the heart of everything we do. Philips Capital has been providing innovative financing solutions globally since 2014. New economic realities, fastchanging technology, and demands for improvements in clinical services, create significant uncertainties in the healthcare landscape, to which Philips Capital is proactively responding.

Building resilient partnerships to provide patient-centric care

Philips and healthcare providers around the world establish longterm partnership agreements to deliver patient-centric care tailored to fulfill patients’ needs and positively impact treatment outcomes by using integrated health technology.

In essence, the partnerships improve the strategic alignment of both organizations, impacting personalized healthcare across the entire patient journey. This also leads to consistently exceeding patient and family expectations of clinical excellence and patient services. To assure success, these partnerships are supported by Atradius DSB, by means of an ECA financing structure attached to a medical equipment export-transaction.

Want to know more?

Download the whitepaper now for a complete overview of how Philips Capital and Atradius DSB are working together to facilitate the export of Philips' healthcare technology worldwide.


Download whitepaper